|
1
|
Swerdlow S, Campo E, Harris NL, et al:
Mature B-cell neoplasms. WHO Classification of Tumours of
Haematopoietic and Lymphoid Tissues. 4th edition. IARC Press; Lyon:
pp. 256–257. 2008
|
|
2
|
Delecluse H, Anagnostopoulos I, Dallenbach
F, et al: Plasmablastic lymphomas of the oral cavity: a new entity
associated with the human immunodeficiency virus infection. Blood.
89:1413–1420. 1997.
|
|
3
|
Tavora F, Gonzalez-Cuyar LF, Sun C-CJ,
Burke A and Zhao XF: Extra-oral plasmablastic lymphoma: report of a
case and review of literature. Hum Pathol. 37:1233–1236. 2006.
|
|
4
|
Thakral C, Thomas L, Gajra A, et al:
Plasmablastic lymphoma in an immunocompetent patient. J Clin Oncol.
27:e78–e81. 2009.
|
|
5
|
Liu JJ, Zhang L, Ayala E, et al: Human
immunodeficiency virus (HIV)-negative plasmablastic lymphoma: a
single institutional experience and literature review. Leuk Res.
35:1571–1577. 2011.
|
|
6
|
Castillo JJ, Winer ES, Stachurski D, et
al: HIV-negative plasmablastic lymphoma: not in the mouth. Clin
Lymphoma Myeloma Leuk. 11:185–189. 2011.
|
|
7
|
Rafaniello Raviele P, Pruneri G and
Maiorano E: Plasmablastic lymphoma: a review. Oral Dis. 15:38–45.
2009.
|
|
8
|
Wang HW, Yang W, Sun JZ, et al:
Plasmablastic lymphoma of the small intestine: Case report and
literature review. World J Gastroenterol. 18:6677–6681. 2012.
|
|
9
|
Castillo J, Pantanowitz L and Dezube BJ:
HIV-associated plasmablastic lymphoma: lessons learned from 112
published cases. Am J Hematol. 83:804–809. 2008.
|
|
10
|
Conteduca V, Sansonno D, Lauletta G, et
al: H. pylori infection and gastric cancer: state of the art
(review). Int J Oncol. 42:5–18. 2013.
|
|
11
|
Gaidano G, Cerri M, Capello D, et al:
Molecular histogenesis of plasmablastic lymphoma of the oral
cavity. Br J Haematol. 119:622–628. 2002.
|
|
12
|
Teruya-Feldstein J, Chiao E, Filippa D, et
al: CD20-negative large-cell lymphoma with plasmablastic features:
a clinically heterogenous spectrum in both HIV-positive and
-negative patients. Ann Oncol. 15:1673–1679. 2004.
|
|
13
|
Hashimoto M, Inaguma S, Kasai K, et al:
Plasmablastic lymphoma of the stomach in an HIV-negative patient.
Pathol Int. 62:763–770. 2012.
|
|
14
|
Boy SC, van Heerden MB, Raubenheimer EJ
and van Heerden WF: Plasmablastic lymphomas with light chain
restriction - plasmablastic extramedullary plasmacytomas? J Oral
Pathol Med. 39:435–439. 2010.
|
|
15
|
Lorsbach RB, Hsi ED, Dogan A and Fend F:
Plasma cell myeloma and related neoplasms. Am J Clin Pathol.
136:168–182. 2011.
|
|
16
|
Folk GS, Abbondanzo SL, Childers EL and
Foss RD: Plasmablastic lymphoma: a clinicopathologic correlation.
Ann Diagn Pathol. 10:8–12. 2006.
|
|
17
|
Castillo JJ, Winer ES, Stachurski D, et
al: Clinical and pathological differences between human
immunodeficiency virus-positive and human immunodeficiency
virus-negative patients with plasmablastic lymphoma. Leuk Lymphoma.
51:2047–2053. 2010.
|
|
18
|
Saba N, Dang D, Saba J, et al: Bortezomib
in plasmablastic lymphoma: a case report and review of the
literature. Onkologie. 36:287–291. 2013.
|
|
19
|
Cao C, Liu T, Zhu H, et al:
Bortezomib-Contained Chemotherapy and Thalidomide Combined With
CHOP (Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone)
Play Promising Roles in Plasmablastic Lymphoma: A Case Report and
Literature Review. Clin Lymphoma Myeloma Leuk. 14:e145–150.
2014.
|
